Swine Vaccines Market Size, Share & Industry Analysis, By Technology (Modified-Live Attenuated Vaccines, Inactivated/Killed Vaccines, Bacterins & Toxoid-Based Vaccines, and Recombinant Subunit Vaccines), By Disease Indication (Porcine Reproductive & Respiratory Syndrome, Porcine Circovirus Diseases, Mycoplasma Pneumonia, and Swine Influenza), By Route of Administration (Intramuscular, Intradermal, Oral, and Subcutaneous), By Distribution Channel (Direct Sales to Integrated Producers, Veterinary Distributors & Wholesalers, and Veterinarian-Led Channels), and Regional Forecast, 2026-2034

Last Updated: September 28, 2026 | Format: PDF | Report ID: FBI118648

Buy Now

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2021-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2021-2024
Growth Rate	CAGR of 7.15% from 2026 to 2034
Unit	Value (USD Billion)
Segmentation	By Technology, Disease Indications, Route of Administration, Distribution Channel, and Region
By Technology	Modified-Live Attenuated Vaccines Inactivated/Killed Vaccines Bacterins and Toxoid-Based Vaccines Recombinant Subunit and Virus-Like Particle Vaccines Viral-Vector and Chimeric Vaccines Nucleic-Acid and Replicon Vaccines Others
By Disease Indication	Porcine Reproductive and Respiratory Syndrome Porcine Circovirus-Associated Diseases Mycoplasma-Associated Enzootic Pneumonia Swine Influenza Enteric Diseases Reproductive Diseases Systemic and Bacterial Diseases Transboundary and Notifiable Diseases Others
By Route of Administration	Intramuscular Intradermal Oral Subcutaneous Others
By Distribution Channel	Direct Sales to Integrated Swine Producers Veterinary Distributors and Wholesalers Veterinarian-Led and Animal-Health Service Channels Agro-Veterinary Retailers and Cooperatives Government and Public Procurement Others
By Region	North America (By Technology, Disease Indications, Route of Administration, Distribution Channel, and Country) U.S. Canada Europe (By Technology, Disease Indications, Route of Administration, Distribution Channel, and Country/Sub-region) Germany U.K. France Spain Italy Scandinavia Rest of Europe Asia Pacific (By Technology, Disease Indications, Route of Administration, Distribution Channel, and Country/Sub-region) China Japan India Australia Southeast Asia Rest of Asia Pacific Latin America (By Technology, Disease Indications, Route of Administration, Distribution Channel, and Country/Sub-region) Brazil Mexico Rest of Latin America Middle East & Africa (By Technology, Disease Indications, Route of Administration, Distribution Channel, and Country/Sub-region) GCC South Africa Rest of the Middle East & Africa